International Journal of Oral Biology

  • 제47권2호
  • /
  • Pages.25-31
  • /
  • 2022
  • /
  • 1226-7155(pISSN)
  • /
  • 2287-6618(eISSN)
대한구강생물학회 (The Korean Academy of Oral Biology)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of lyosphosphatidic acid receptor 1 signaling in periodontal ligament stem cells reduces inflammatory paracrine effect in primary astrocyte cells

  • Kim, Dong Hee (Department of Oral Biochemistry, Pusan National University School of Dentistry) ;
  • Seo, Eun Jin (Department of Oral Biochemistry, Pusan National University School of Dentistry) ;
  • Kim, Young Hwan (Department of Oral Biochemistry, Pusan National University School of Dentistry) ;
  • Jang, Il Ho (Department of Oral Biochemistry, Pusan National University School of Dentistry)
  • 투고 : 2022.06.09
  • 심사 : 2022.06.14
  • 발행 : 2022.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Lysophosphatidic acid (LPA) is a bioactive lipid messenger involved in the pathogenesis of chronic inflammation and various diseases. Recent studies have shown an association between periodontitis and neuroinflammatory diseases such as Alzheimer's disease, stroke, and multiple sclerosis. However, the mechanistic relationship between periodontitis and neuroinflammatory diseases remains unclear. The current study found that lysophosphatidic acid receptors 1 (LPAR1) and 6 (LPAR6) exhibited increased expression in primary microglia and astrocytes. The primary astrocytes were then treated using medium conditioned to mimic periodontitis through addition of Porphyromonas gingivalis lipopolysaccharides, and an increased nitric oxide (NO) production was observed. Application of conditioned medium from human periodontal ligament stem cells with or without LPAR1 knockdown showed a decrease in the production of NO and expression of inducible nitric oxide synthase and interleukin 1 beta. These findings may contribute to our understanding of the mechanistic link between periodontitis and neuroinflammatory diseases.

키워드

과제정보

This work was supported by a 2-Year Research Grant of Pusan National University.

참고문헌

  1. Cardoso EM, Reis C, Manzanares-Cespedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad Med 2018;130:98-104. doi: 10.1080/00325481.2018.1396876.
  2. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008;23:2079-86. doi: 10.1007/s11606-008-0787-6.
  3. Kaur S, White S, Bartold PM. Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res 2013;92:399-408. doi: 10.1177/0022034513483142.
  4. Furutama D, Matsuda S, Yamawaki Y, Hatano S, Okanobu A, Memida T, Oue H, Fujita T, Ouhara K, Kajiya M, Mizuno N, Kanematsu T, Tsuga K, Kurihara H. IL-6 induced by periodontal inflammation causes neuroinflammation and disrupts the blood-brain barrier. Brain Sci 2020;10:679. doi: 10.3390/brainsci10100679.
  5. Wang X, Tong Y, Zhang J, Khan N, Zhang K, Bai H, Zhang Q, Chen Y. Neuroinflammation changes with periodontal inflammation status during periodontitis in wild-type mice. Oral Dis 2021;27:1001-11. doi: 10.1111/odi.13618.
  6. Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 2019;10:1008. doi: 10.3389/fphar.2019.01008.
  7. Schwartz M, Deczkowska A. Neurological disease as a failure of brain-immune crosstalk: the multiple faces of neuroinflammation. Trends Immunol 2016;37:668-79. doi: 10.1016/j.it.2016.08.001.
  8. Teixeira FB, Saito MT, Matheus FC, Prediger RD, Yamada ES, Maia CSF, Lima RR. Periodontitis and Alzheimer's disease: a possible comorbidity between oral chronic inflammatory condition and neuroinflammation. Front Aging Neurosci 2017;9:327. doi: 10.3389/fnagi.2017.00327.
  9. Alvarenga MOP, Frazao DR, de Matos IG, Bittencourt LO, Fagundes NCF, Rosing CK, Maia LC, Lima RR. Is there any association between neurodegenerative diseases and periodontitis? A systematic review. Front Aging Neurosci 2021;13:651437. doi: 10.3389/fnagi.2021.651437.
  10. Kim DH, Seo EJ, Tigyi GJ, Lee BJ, Jang IH. The role of lysophosphatidic acid receptor 1 in inflammatory response induced by lipopolysaccharide from Porphyromonas gingivalis in human periodontal ligament stem cells. Int J Oral Biol 2020;45:42-50. doi: 10.11620/IJOB.2020.45.2.42.
  11. Birgbauer E. Lysophosphatidic acid signalling in nervous system development and function. Neuromolecular Med 2021; 23:68-85. doi: 10.1007/s12017-020-08630-2.
  12. Geraldo LHM, Spohr TCLS, Amaral RFD, Fonseca ACCD, Garcia C, Mendes FA, Freitas C, dosSantos MF, Lima FRS. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct Target Ther 2021;6:45. doi: 10.1038/s41392-020-00367-5.
  13. Ahmadzai MM, McClain JL, Dharshika C, Seguella L, Giancola F, De Giorgio R, Gulbransen BD. LPAR1 regulates enteric nervous system function through glial signaling and contributes to chronic intestinal pseudo-obstruction. J Clin Invest 2022;132:e149464. doi: 10.1172/JCI149464.
  14. Nagata M, Iwasaki K, Akazawa K, Komaki M, Yokoyama N, Izumi Y, Morita I. Conditioned medium from periodontal ligament stem cells enhances periodontal regeneration. Tissue Eng Part A 2017;23:367-77. doi: 10.1089/ten.TEA.2016.0274.
  15. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 2010;50:157-86. doi: 10.1146/annurev.pharmtox.010909.105753.
  16. Stoddard NC, Chun J. Promising pharmacological directions in the world of lysophosphatidic Acid signaling. Biomol Ther (Seoul) 2015;23:1-11. doi: 10.4062/biomolther.2014.109.
  17. Xiang H, Lu Y, Shao M, Wu T. Lysophosphatidic acid receptors: biochemical and clinical implications in different diseases. J Cancer 2020;11:3519-35. doi: 10.7150/jca.41841.
  18. Valdes-Rives SA, Gonzalez-Arenas A. Autotaxin-lysophosphatidic acid: from inflammation to cancer development. Mediators Inflamm 2017;2017:9173090. doi: 10.1155/2017/9173090.
  19. Goldshmit Y, Munro K, Leong SY, Pebay A, Turnley AM. LPA receptor expression in the central nervous system in health and following injury. Cell Tissue Res 2010;341:23-32. doi: 10.1007/s00441-010-0977-5.
  20. Yung YC, Stoddard NC, Mirendil H, Chun J. Lysophosphatidic Acid signaling in the nervous system. Neuron 2015;85:669-82. doi: 10.1016/j.neuron.2015.01.009. Erratum in: Neuron 2015;86:341.
  21. Gross I, Brauer AU. Modulation of lysophosphatidic acid (LPA) receptor activity: the key to successful neural regeneration? Neural Regen Res 2020;15:53-4. doi: 10.4103/1673-5374.264452.
  22. Frugier T, Crombie D, Conquest A, Tjhong F, Taylor C, Kulkarni T, McLean C, Pebay A. Modulation of LPA receptor expression in the human brain following neurotrauma. Cell Mol Neurobiol 2011;31:569-77. doi: 10.1007/s10571-011-9650-0.
  23. Kotova AV, Lobov AA, Dombrovskaya JA, Sannikova VY, Ryumina NA, Klausen P, Shavarda AL, Malashicheva AB, Enukashvily NI. Comparative analysis of dental pulp and periodontal stem cells: differences in morphology, functionality, osteogenic differentiation and proteome. Biomedicines 2021;9:1606. doi: 10.3390/biomedicines9111606.
  24. Nonaka S, Kadowaki T, Nakanishi H. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins. Neurochem Int 2022;154:105282. doi: 10.1016/j.neuint.2022.105282.
  25. Darveau RP, Hajishengallis G, Curtis MA. Porphyromonas gingivalis as a potential community activist for disease. J Dent Res 2012;91:816-20. doi: 10.1177/0022034512453589.